Vertex Pharmaceuticals Incorporated (VRTX) research: valuation against peers, fundamentals over time, risk and news coverage

VRTX

Vertex Pharmaceuticals Incorporated
USD
548
+1.44% today
Market cap
P/E trailing
P/E forward
EV/EBITDA
Op margin
Rev growth
Div yield
Beta
52-week range376.62552.061 report(s) in our archive
Price navigator — VRTX

No data in this window.

    INDY NEWS coverage of VRTX1

    Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.

    • BREAKING STORYNEUTRAL
      SEC Moves on Two Fronts: Tricolor Enforcement and a Crypto Offering Framework

      The Securities and Exchange Commission filed charges against former executives of failed auto lender Tricolor and simultaneously advanced a bespoke rulemaking for crypto asset offerings, signalling parallel tracks of enforcement against subprime credit misconduct and accommodation for tokenized capital formation.

    Full archive search for VRTX

    Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.